TELEXOS

We want to be the first company to bring CTC-analysis into the clinical routine to save lives and costs... CTCs reflects the tumor diversity on all levels (protein, DNA, RNA and cellular). Therefore, we believe that CTC will finally be the mostly used analyte to detect and characterize solid tumors and in addition monitor cancer therapy in a personalized manner. This will make cancer therapy more efficient, more cost-effective and more patient-friendly.

Also known as: Telexos GmbH

Primary location: Weilheim In Oberbayern Chile